CSS
TXG icon

Cubist Systematic Strategies’s 10x Genomics TXG Stock Holding History

Cubist Systematic Strategies’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-334,632
Closed -$4.81M – 3548
2024
Q4 		$4.81M Buy
334,632
+110,682
+49% +$1.75M 0.03% 860
2024
Q3 		$5.06M Buy
+223,950
New +$4.63M 0.03% 828
2024
Q2 		– Sell
-365,322
Closed -$13.7M – 4045
2024
Q1 		$13.7M Buy
365,322
+241,958
+196% +$10.6M 0.08% 341
2023
Q4 		$6.9M Buy
123,364
+59,866
+94% +$2.6M 0.04% 673
2023
Q3 		$2.62M Sell
63,498
-105,351
-62% -$5.48M 0.02% 1182
2023
Q2 		$9.43M Buy
+168,849
New +$9.14M 0.06% 463
2023
Q1 		– Sell
-175,048
Closed -$6.38M – 4440
2022
Q4 		$6.38M Sell
175,048
-55,399
-24% -$1.81M 0.04% 814
2022
Q3 		$6.56M Buy
230,447
+52,941
+30% +$2.02M 0.04% 810
2022
Q2 		$8.03M Buy
177,506
+48,890
+38% +$2.54M 0.05% 601
2022
Q1 		$9.78M Buy
128,616
+126,018
+4,851% +$11M 0.08% 309
2021
Q4 		$387K Sell
2,598
-2,968
-53% -$455K ﹤0.01% 2629
2021
Q3 		$810K Sell
5,566
-10,114
-65% -$1.74M 0.01% 1687
2021
Q2 		$3.07M Buy
15,680
+15,607
+21,379% +$2.82M 0.03% 817
2021
Q1 		$13K Sell
73
-24,228
-100% -$4.18M ﹤0.01% 2780
2020
Q4 		$3.44M Sell
24,301
-14,102
-37% -$2.05M 0.05% 637
2020
Q3 		$4.79M Buy
38,403
+28,637
+293% +$3.01M 0.07% 431
2020
Q2 		$872K Buy
9,766
+9,685
+11,957% +$754K 0.02% 1263
2020
Q1 		$5K Sell
81
-3,183
-98% -$248K ﹤0.01% 2098
2019
Q4 		$249K Buy
3,264
+2,087
+177% +$125K ﹤0.01% 1941
2019
Q3 		$59K Buy
+1,177
New +$65.1K ﹤0.01% 2018

Other funds holding TXG

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Cubist Systematic Strategies's TXG Position: Q1 2025 in Review

Cubist Systematic Strategies sold out of 10x Genomics (TXG) in Q1 2025, closing a stake of 334,632 shares — an estimated $4.81M sold.

Cubist Systematic Strategies first reported a position in TXG in Q3 2019 and held it in 20 quarters. The position peaked at $13.7M in Q1 2024. 274 funds tracked by Wall St. Rank hold TXG as of Q1 2025.

  • Cubist Systematic Strategies reported no remaining 10x Genomics position as of Q1 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 334,632 10x Genomics shares in Q1 2025, an estimated $4.81M.
  • Cubist Systematic Strategies first reported a position in 10x Genomics in Q3 2019 and held it in 20 quarters.
  • Cubist Systematic Strategies's 10x Genomics position peaked at $13.7M in Q1 2024.
  • 274 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2025.

Based on Cubist Systematic Strategies's 13F filing for Q1 2025, filed 15 May 2025.